Wu Y, Lu J X, Yan Z Z, Liu Y X, Gu W P, Fu X Q, Xu Y C, Wu A H, Huang H H, Zong Z Y, Jin D Z, Zhao J H, Chen Y, Liu W P, Li W G
National Institute for Communicable Disease Control and Prevention, Chines Center for Disease Control and Prevention, Beijing 102206, China.
Chinese People' s Liberation Army General Hospital, Beijing 100853, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Jan 10;42(1):64-67. doi: 10.3760/cma.j.cn112338-20201026-01272.
is a key pathogen of antibiotic related diarrhea and hospital associated infection, causing several outbreaks in Europe and North Americans and resulting in severe disease burden. However, the standardized diagnostic principle and detection specifications in . infection (CDI) survey are limited in China, and the infection rate and disease burden of CDI in China are unclear. Therefore, National Institute for Communicable Disease Control and Prevention,National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, together with another 11 institutions, draft the group standard entitled "Diagnosis of infection (T/CPMA 008-2020)" of Chinese Preventive Medicine Association. Based on the principle of "legality, scientificity, advancement, and feasibility", this standard clarifies risk factors, diagnosis principles, diagnoses and differential diagnoses in order to improve the accuracy of CDI diagnosis in clinical practice, guide the surveillance for CDI, and understand the infection rate and disease burden of CDI in China
是抗生素相关性腹泻和医院感染的关键病原体，在欧洲和北美引发了多次疫情，并导致了严重的疾病负担。然而，中国艰难梭菌感染（CDI）调查中的标准化诊断原则和检测规范有限，中国CDI的感染率和疾病负担尚不清楚。因此，中国疾病预防控制中心传染病预防控制所与另外11家机构共同起草了中国预防医学会团体标准《艰难梭菌感染诊断（T/CPMA 008—2020）》。本标准基于“合法性、科学性、先进性、可行性”原则，明确了危险因素、诊断原则、诊断及鉴别诊断，以提高临床实践中CDI诊断的准确性，指导CDI监测，了解中国CDI的感染率和疾病负担
